Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | +2.35% | +10.13% | +13.73% |
May. 02 | Transcript : Lexicon Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (LXRX) LEXICON PHARMACEUTICALS Posts Q1 Revenue $1.1M, vs. Street Est of $1.4M | MT |
Financials (USD)
Sales 2024 * | 20.21M | Sales 2025 * | 78.97M | Capitalization | 428M |
---|---|---|---|---|---|
Net income 2024 * | -209M | Net income 2025 * | -195M | EV / Sales 2024 * | 21.2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.43 x |
P/E ratio 2024 * |
-2.17
x | P/E ratio 2025 * |
-2.47
x | Employees | 285 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.71% |
Latest transcript on Lexicon Pharmaceuticals, Inc.
1 day | +2.35% | ||
1 week | +10.13% | ||
Current month | +12.99% | ||
1 month | -14.71% | ||
3 months | -18.31% | ||
6 months | +17.57% | ||
Current year | +13.73% |
Managers | Title | Age | Since |
---|---|---|---|
Lonnel Coats
CEO | Chief Executive Officer | 58 | 14-07-06 |
Jeffrey Wade
DFI | Director of Finance/CFO | 59 | 98-12-31 |
Craig Granowitz
CTO | Chief Tech/Sci/R&D Officer | 60 | 21-08-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Lefkowitz
BRD | Director/Board Member | 80 | 01-01-31 |
Ray Debbane
CHM | Chairman | 69 | 07-07-31 |
Director/Board Member | 65 | 07-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.74 | +2.35% | 5,866,568 |
24-05-02 | 1.7 | +3.03% | 4,643,859 |
24-05-01 | 1.65 | +7.14% | 7,090,148 |
24-04-30 | 1.54 | -1.28% | 3,573,328 |
24-04-29 | 1.56 | -1.27% | 2,213,745 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.73% | 428M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- LXRX Stock